Kirk Schanze, PhD, a co-inventor of the technology owned by BioSafe Defenses, LLC leaves the University of Florida to become Chairman of the Chemistry Department of the University of Texas at San Antonio.
Dr. Joel Friedman, MD, PhD, Professor of Physiology, Biophysics and Medicine at the Albert Einstein College of Medicine in New York joins the Medical Advisory Board of BioSafe Defenses, LLC.
Dr. Michael Waldmeier, PhD, DDM, joins BioSafe Defenses, LLC as Chief Technical Officer and he opens the Frankfurt, Germany office of BioSafe Defenses,LLC.
BioSafe Defenses Receives Their 13th U.S. Patent #10,174,042 B2 “Structure, Synthesis and Application for Poly (Phenylene) Ethnylenes (PPES).
U.S. Patent #15/368,148 Dr. Michael Waldmeier, PhD, DDM, joins BioSafe Defenses, LLC as Chief Technical Officer and he opens the Frankfurt, Germany office of BioSafe Defenses, LLC.
U.S. Patent #14/533,612 Charged singlet-oxygen sensitizers and oppositely charged surfactants issued, the 11th patent issued to BioSafe Defenses, LLC.
U.S. Patent #9,750,250 Conjugated polyelectrolytes and methods of using the same patent issued, the 10th patent issued to BioSafe Defenses, LLC.
BIOSAFE Defenses Secures 17th Patent on Its Antimicrobial Materials and Methods
ALBUQUERQUE, N.M. (February 1, 2017) The extensive patent portfolio of BIOSAFE Defenses, LLC, a New Mexico-based company focused on the commercialization of antimicrobial technologies, has expanded by one. On January 24, the U.S. Patent Office awarded a patent protecting methods and materials for the decontamination of surfaces and fabrics. BIOSAFE now has exclusive rights to … Continued
U.S. Patent #9,549,549 Antimicrobial materials and methods patent issued, the 9th patent issued to BioSafe Defenses, LLC.
Antimicrobial materials and methods patent issued, the 9th patent issued to BioSafe Defenses, LLC.